Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET.

MLA

Kaiser, Lena, et al. “Enhancing Predictability of IDH Mutation Status in Glioma Patients at Initial Diagnosis: A Comparative Analysis of Radiomics from MRI, [18F]FET PET, and TSPO PET.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 8, July 2024, pp. 2371–81. EBSCOhost, https://doi.org/10.1007/s00259-024-06654-5.

APA

Kaiser, L., Quach, S., Zounek, A. J., Wiestler, B., Zatcepin, A., Holzgreve, A., Bollenbacher, A., Bartos, L. M., Ruf, V. C., Böning, G., Thon, N., Herms, J., Riemenschneider, M. J., Stöcklein, S., Brendel, M., Rupprecht, R., Tonn, J. C., Bartenstein, P., von Baumgarten, L., & Ziegler, S. (2024). Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET. European Journal of Nuclear Medicine & Molecular Imaging, 51(8), 2371–2381. https://doi.org/10.1007/s00259-024-06654-5

Chicago

Kaiser, Lena, S. Quach, A. J. Zounek, B. Wiestler, A. Zatcepin, A. Holzgreve, A. Bollenbacher, et al. 2024. “Enhancing Predictability of IDH Mutation Status in Glioma Patients at Initial Diagnosis: A Comparative Analysis of Radiomics from MRI, [18F]FET PET, and TSPO PET.” European Journal of Nuclear Medicine & Molecular Imaging 51 (8): 2371–81. doi:10.1007/s00259-024-06654-5.